Morgan Stanley Lifts RAL Target to $85 as Bulls Dominate Options
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Morgan Stanley raised its price target on RAL to $85 this morning — a 25% jump from its prior $68 — while maintaining an Overweight rating. The stock trades at $69.22. That gap between the new target and current price is the headline story today.
Analysts Keep Lifting the Bar
Morgan Stanley's Chris Snyder has now raised his RAL target three times since May. The progression: $45 → $68 → $85. TD Cowen, Citigroup, and Barclays all raised targets in May as well. Every firm held its bullish rating. Not one downgrade in the recent history.
The mean consensus target sits at $68.55 — now below the current price. Morgan Stanley's fresh $85 is well above the pack.
Options Market Leans Hard Bullish
The put/call ratio hit 0.029 on June 23. The 20-day average is 0.38. That's 2.75 standard deviations below the mean — extreme call dominance. For context, the PCR was running above 0.47 for most of early June. Something shifted sharply in the past two sessions.
Bullish options positioning and a Street that keeps raising targets are pointing the same direction.
Short Sellers Are Stepping Back
Shares short fell nearly 20% in a single day to 5.7 million. That continues a broader retreat — short interest is down 17% over the past week. The borrow market is wide open. Availability stands at 3,477% of estimated shorts, meaning roughly 34 shares are available to lend for every one currently borrowed. Cost to borrow is just 0.36%, near multi-month lows despite a week-on-week uptick.
The previous article flagged a one-day SI spike on June 16 as likely noise. That call was right — shorts have since unwound.
Institutional Support Is Notable
Dodge & Cox holds 12.3% of shares. Vanguard Portfolio Management entered with a full 7.6% stake. Irenic Capital added 1.4 million shares last reported period. Point72 added 785,000. The holder base looks engaged.
What to watch: Whether the stock can close the gap to Morgan Stanley's $85 target. The next earnings date is August 11.
- Price: $69.22, up 2.2% on the day, +12.5% over the past month
- PCR: 0.029 vs. 20-day mean of 0.38 (z-score: −2.75)
- Short interest: 5.7M shares, −19.6% in one day
- Availability: 3,477% — very loose borrow market
- Cost to borrow: 0.36%
- Morgan Stanley target: $85 (raised from $68 today)
Stocks in this article
See the live data behind this article on ORTEX.
Open RAL on ORTEX →How this article was generated
- Generated
- 24 Jun 2026, 11:11
- Data as of
- 24 Jun 2026, 11:06
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.